Recent Advances in Measuring Response to Immune Checkpoint Inhibitors

This Cancer Research Catalyst blog post discusses efforts to find efficient, noninvasive ways to identify patients who are likely to benefit from this form of immunotherapy.

AACR in the News

CAR-T cancer therapy is potent, but can be lethal. New research helps explain why

STAT News covered a recent study in the AACR’s journal Cancer Discovery that identified risk factors for neurotoxicity following CAR T-cell therapy, a finding that could improve how doctors manage this dangerous side effect.